Immune cell signaling pathway

Immune cell signaling pathway" is not a single molecule or receptor, but rather refers to an extensive network of interconnected biochemical routes that regulate how immune cells detect threats and coordinate responses. These include both innate and adaptive immunity. Key components involve pattern-recognition receptors like Toll-like receptors, RIG-I-like receptors, Nod-like receptors in innate immunity; T-cell receptor and B-cell receptor signaling in adaptive immunity; and downstream effectors such as NF-kB, JAK/STAT, cGAS–STING pathways among others. These cascades control processes including cytokine release, cellular activation/proliferation/differentiation/apoptosis, antibody production by B-cells upon antigen recognition via their surface immunoglobulins/BCRs, cytotoxic activity by T-cells upon TCR engagement, macrophage polarization, NK cell function, etc. Dysregulation at any point can contribute to diseases such as cancer—by shaping tumor microenvironments—or autoimmune disorders through inappropriate activation/suppression. Therapeutic drugs do not target "immune cell signaling pathway" per se but act on individual nodes like kinases/receptors/transcription factors within these networks. Because this term does not refer to a discrete protein/gene/receptor/enzyme/transporter/etc., it is not considered a therapeutic target in itself. Note: The entry "Immune cell signaling pathway" is too broad/vague for structured drug-target information. It describes multiple biological processes involving many distinct molecules that may themselves be valid targets. For structured data extraction purposes you should use more precise terms referring to individual proteins/receptors/enzymes involved in these pathways instead.

Other names

Immune signaling pathwayImmune cell signalingImmune pathwaysImmunological signaling cascades

Mechanisms depend on the specific molecular target within the pathway; for example, inhibition of kinases or receptors such as JAK/STAT or Toll-like receptors.